Tehran – The Iran National Institute of Genetic Engineering and Biotechnology (NIGEB) has developed an anti-cancer vaccine that will be released in the summer.
“The vaccines will prevent all cancers,” Mehr’s news outlet quotes Nigeb’s director Javad Mohammadi.
Referring to two new products produced by Iranian knowledge-based companies, namely intravenous immunoglobulin (IVIG) and albumin, officials said IVIG is essential for patients with innate immune deficiency. Due to weak immune systems, these patients require immunoglobulin injections every 20 days.
Currently, to meet the patient’s needs, plasma is sent to other countries to transform it into a variety of proteins, including immunoglobulins, and the products are imported for patients to use. The process is not only expensive, but time consuming, Mohammadi noted.
Albumin is a type of protein produced by the liver. He added that it is important for patients suffering from kidney and liver diseases to prevent fluid from leaking through blood vessels.
“These two products are now available to patients in the domestic market. Knowledge-based companies will soon be able to meet 70% and then meet 100% of the market needs. “Mohammadi emphasized.
National Institute of Genetic Engineering and Biotechnology
Nigeb was founded in 1989 under the supervision of the Ministry of Science, Research and Technology. Since then, Nigeb has been obligated to carry out original, cutting-edge research activities.
Established with the dual purpose of promoting research in the avant-garde fields of biological sciences and biotechnology, it provided advanced training and educational programs to scientists and students from other universities and academic institutions.
Nigeb is a key hub for advancing the Iranian biotechnology field, and is noteworthy for its focus on interdisciplinary collaboration and ethical advances.
Impressively, they engage in both basic and applied research in a variety of biotechnology fields, taking into account the implications of technological commercialization and socioeconomic impacts.
Nigeb’s commitment to global cooperation and knowledge sharing is essential, especially in domains that evolve rapidly, as quickly as genetic engineering and biotechnology.
Their work not only contributes to the scientific community within Iran, but also to international efforts to address complex issues in agriculture, industry, the environment and health. This reflects a comprehensive approach to research and education in this field.
mt/mg